Cargando…
Alternative polyadenylation drives oncogenic gene expression in pancreatic ductal adenocarcinoma
Alternative polyadenylation (APA) is a gene regulatory process that dictates mRNA 3′-UTR length, resulting in changes in mRNA stability and localization. APA is frequently disrupted in cancer and promotes tumorigenesis through altered expression of oncogenes and tumor suppressors. Pan-cancer analyse...
Autores principales: | Venkat, Swati, Tisdale, Arwen A., Schwarz, Johann R., Alahmari, Abdulrahman A., Maurer, H. Carlo, Olive, Kenneth P., Eng, Kevin H., Feigin, Michael E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7111527/ https://www.ncbi.nlm.nih.gov/pubmed/32029502 http://dx.doi.org/10.1101/gr.257550.119 |
Ejemplares similares
-
Alternative polyadenylation is a determinant of oncogenic Ras function
por: Subramanian, Aishwarya, et al.
Publicado: (2021) -
Lorazepam Stimulates IL6 Production and Is Associated with Poor Survival Outcomes in Pancreatic Cancer
por: Cornwell, Abigail C., et al.
Publicado: (2023) -
Alternative polyadenylation of cyclooxygenase-2
por: Hall-Pogar, Tyra, et al.
Publicado: (2005) -
Alternative Polyadenylation in Human Diseases
por: Chang, Jae-Woong, et al.
Publicado: (2017) -
Extensive alternative polyadenylation during zebrafish development
por: Ulitsky, Igor, et al.
Publicado: (2012)